News Sentiment

HCAT sentiment intelligence

Health Catalyst Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 47 Balanced news tone 62 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Health Information Services Read-through group
Latest close 2.29 Week of 10 Jul 2026
Weighted tone 47/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

80/100 classification confidence.

Company focus 62

directly relevant articles

Source quality 0

high-authority source matches

Trend context Trend inactive

+10.1% over one week, +23.8% over four weeks, trend inactive, and below fair value.

Latest direct headline Negative

3 Reasons to Sell HCAT and 1 Stock to Buy Instead

Market Reaction

Price moving ahead of tone

62/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 80/100 classification
One-week reaction 10.1% Price confirming higher
Trend fit Trend inactive 23.8% over four weeks
Fair value -59.5% Below fair value
Value support

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 7
Neutral 41
Negative 14

Relevance

Why the article matched

Direct first
Direct company coverage 62
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
Stock Titan 17
Market source 12
TradingView 6
StockStory 4
The Globe and Mail 3
www.marketscreener.com 3
TradingKey 3
simplywall.st 3

Event Lens

What the news is about

Classified themes
Market update 35
Earnings 16
Deals and strategy 4
Balance sheet 4
Analyst action 1
Regulatory and legal 1
Macro sensitivity 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-30 of 62
StockStory Direct company coverage

3 Reasons to Sell HCAT and 1 Stock to Buy Instead

This article recommends selling Health Catalyst (HCAT) due to its stagnant billings, low gross margins, and long customer acquisition cost payback periods, which indicate weak structural profitability and inefficiency. The authors express a lack of confidence in HCAT's future per

Tone
Negative 19/100
Event
Deals and strategy
Published
14 Jul 2026 17:41
Source
StockStory
HCI Innovation Group Direct company coverage

Health Catalyst Sells Vitalware to Double Down on AI Strategy

Health Catalyst has sold its Vitalware mid-revenue-cycle business to Med-Metrix for $147 million in cash. This strategic move aims to sharpen Health Catalyst's focus on artificial intelligence, analytics, and its core technology platform, while also strengthening its financial po

Tone
Positive 70/100
Event
Balance sheet
Published
12 Jul 2026 18:10
Source
HCI Innovation Group
The Globe and Mail Direct company coverage

monday.com, Intuit, and Health Catalyst Stocks Trade Down, What You Need To Know

Shares of monday.com, Intuit, and Health Catalyst all dropped approximately 3.3% after President Trump declared an Iran ceasefire "over," which led to an increase in oil prices and bond yields. This negatively impacted high-multiple tech software stocks, as their valuations are s

Tone
Negative 39/100
Event
Market update
Published
09 Jul 2026 04:41
Source
The Globe and Mail
Moomoo Direct company coverage

Health Catalyst(HCAT) Stock Options Chain | Quotes & News

This article provides information on Health Catalyst (HCAT) stock options, including quotes and relevant news. It focuses on offering a detailed look at the company's financial instruments and market performance.

Tone
Neutral 50/100
Event
Market update
Published
09 Jul 2026 04:10
Source
Moomoo
TradingView Direct company coverage

Price to earnings forward of Health Catalyst, Inc – NASDAQ:HCAT

This article displays the "Price to earnings forward" metric for Health Catalyst, Inc (NASDAQ: HCAT) on the TradingView platform. It provides a financial overview of the company, focusing on this specific valuation ratio. The content is primarily a listing of financial data and n

Tone
Neutral 50/100
Event
Earnings
Published
08 Jul 2026 02:09
Source
TradingView
TradingView Direct company coverage

Price to sales forward of Health Catalyst, Inc – NASDAQ:HCAT

This article provides the "Price to sales forward" metric for Health Catalyst, Inc (NASDAQ: HCAT). It appears to be a financial data point from TradingView, indicating the company's valuation based on future sales. The content is primarily a listing of financial and platform feat

Tone
Neutral 50/100
Event
Market update
Published
07 Jul 2026 03:40
Source
TradingView
Simply Wall Street Direct company coverage

Discover Health Catalyst And 2 More Promising Penny Stocks

This article identifies three promising penny stocks - Health Catalyst (HCAT), Resources Connection (RGP), and Mammoth Energy Services (TUSK) - highlighting their financials, growth potential, and recent developments. While all three face challenges such as unprofitability or mar

Tone
Negative 38/100
Event
Market update
Published
06 Jul 2026 17:39
Source
Simply Wall Street
TradingView Direct company coverage

Price to book forward of Health Catalyst, Inc – NASDAQ:HCAT

The article discusses the forward price-to-book ratio for Health Catalyst, Inc. (NASDAQ: HCAT). It appears to be a financial data snippet from TradingView, indicating a focus on the company's valuation metric rather than providing detailed analysis. The content is sparse, highlig

Tone
Neutral 50/100
Event
Market update
Published
04 Jul 2026 08:39
Source
TradingView
Finviz Direct company coverage

HCAT - Health Catalyst Inc Options

This article provides a detailed financial overview of Health Catalyst Inc (HCAT), including its stock performance, key financial metrics, and company statistics. It covers market capitalization, sales, income, various ratios, employee count, IPO date, and recent insider and inst

Tone
Neutral 50/100
Event
Market update
Published
02 Jul 2026 01:41
Source
Finviz
www.marketscreener.com Direct company coverage

Health Catalyst, Inc.(NasdaqGS: HCAT) dropped from Russell 2000 Value Benchmark

Health Catalyst, Inc. (NasdaqGS: HCAT) has been dropped from the Russell 2000 Value Benchmark, effective June 29, 2026. This exclusion is part of broader removals from several Russell indices, including the Russell 2000, Russell 3000E, Russell 3000, Russell 2500, and various asso

Tone
Negative 28/100
Event
Market update
Published
30 Jun 2026 01:09
Source
www.marketscreener.com
www.marketscreener.com Direct company coverage

Health Catalyst, Inc.(NasdaqGS: HCAT) dropped from Russell 2000 Index

Health Catalyst, Inc. (NasdaqGS: HCAT) has been removed from the Russell 2000 Index, as well as the Russell 2000 Value Benchmark, Russell 3000E Index, and Russell 3000 Index. This news follows several other recent developments for the company, including the sale of its Vitalware

Tone
Negative 28/100
Event
Market update
Published
29 Jun 2026 18:51
Source
www.marketscreener.com
www.marketscreener.com Direct company coverage

Health Catalyst, Inc.(NasdaqGS: HCAT) dropped from Russell 3000E Index

Health Catalyst, Inc. (NasdaqGS: HCAT) has been dropped from the Russell 3000E Index. This news comes shortly after the company announced its agreement to sell Vitalware, LLC for approximately $150 million, and also reported its Q1 2026 earnings with impairment charges and a work

Tone
Negative 40/100
Event
Earnings
Published
29 Jun 2026 10:12
Source
www.marketscreener.com
TradingKey Direct company coverage

Health Catalyst Inc (HCAT) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of Health Catalyst Inc (HCAT), focusing on its support and resistance levels, price momentum, and various technical indicators and moving averages. HCAT's current price momentum is 7.09, suggesting range-bound swing trading between resis

Tone
Positive 71/100
Event
Market update
Published
27 Jun 2026 08:40
Source
TradingKey
GuruFocus Direct company coverage

HCAT Maintained by Wells Fargo -- Price Target Raised to $1.75

Wells Fargo analyst Stan Berenshteyn has maintained an "Equal-Weight" rating for Health Catalyst (HCAT) and raised the price target to $1.75 from $1.00, a 75% increase. Despite this positive adjustment, Health Catalyst's GF Score™ is 49/100, indicating moderate potential but also

Tone
Positive 63/100
Event
Analyst action
Published
26 Jun 2026 20:08
Source
GuruFocus
TradingKey Direct company coverage

Health Catalyst Inc (HCAT) Financial Health: Profitability & Balance Sheet Analysis

Health Catalyst Inc (HCAT) currently has a weak financial status with a financial score of 6.67 out of 487 in the Software & IT Services industry. The company's latest quarterly revenue decreased by 10.90% year-over-year to $70.76M, and its net profit saw a significant decrease o

Tone
Negative 26/100
Event
Earnings
Published
26 Jun 2026 12:09
Source
TradingKey
TradingView Direct company coverage

Data Analytics Stocks Q1 Highlights: Health Catalyst (NASDAQ:HCAT)

This article provides a Q1 earnings overview for several data analytics companies, highlighting Health Catalyst (HCAT) as having solid results but with weakest guidance updates. It contrasts HCAT's performance with Palantir Technologies (PLTR) which showed strong revenue growth,

Tone
Neutral 50/100
Event
Earnings
Published
23 Jun 2026 10:12
Source
TradingView
The Globe and Mail Direct company coverage

Health Catalyst, Zoom, and Autodesk Shares Are Falling, What You Need To Know

Shares of Health Catalyst, Zoom, and Autodesk declined following widespread fears that AI agents could erode traditional enterprise software subscription models, further compounded by high-profile AI talent departures and regulatory overhangs. The market is pricing in significant

Tone
Negative 19/100
Event
Regulatory and legal
Published
22 Jun 2026 21:41
Source
The Globe and Mail
Stock Titan Direct company coverage

Palogic reports 6.7% Health Catalyst (HCAT) stake and outlines possible actions

Palogic-related entities and Ryan L. Vardeman have disclosed a beneficial ownership of 6.7% in Health Catalyst (HCAT), totaling 4,918,866 shares acquired for approximately $11 million. While stating the investment is for ordinary purposes, the filing outlines potential future act

Tone
Neutral 50/100
Event
Deals and strategy
Published
22 Jun 2026 20:11
Source
Stock Titan
TradingView Direct company coverage

Ryan L. Vardeman discloses investment at Health Catalyst with 6.7% stake

Ryan L. Vardeman, through Palogic-affiliated entities, has acquired a 6.7% stake in Health Catalyst, Inc. common stock, crossing the reporting threshold on June 12, 2026. The filing indicates plans for active engagement with Health Catalyst's management and board, expressing supp

Tone
Positive 66/100
Event
Deals and strategy
Published
22 Jun 2026 19:40
Source
TradingView
TradingKey Direct company coverage

Health Catalyst Inc (HCAT) Earnings Forecast: Future EPS & Revenue Growth Estimates

Health Catalyst Inc (HCAT) has an earnings forecast score of 6.75, ranking 334 out of 489 in its industry. Analysts have an average price target of $4.00, with a consensus "Hold" rating based on 7 analysts. The company's expected revenue for the next quarter is $68.97M, with an a

Tone
Neutral 50/100
Event
Earnings
Published
17 Jun 2026 16:10
Source
TradingKey
The Globe and Mail Direct company coverage

Health Catalyst to Participate in Upcoming Investor Conference

Health Catalyst, Inc. announced its participation in the Truist Securities Healthcare Disruptors & Digital Health Conference. Senior management members will attend, with CEO Ben Albert participating in a panel discussion on "AI ROI in Healthcare: Real vs Hype Debate" on June 24,

Tone
Positive 59/100
Event
Market update
Published
17 Jun 2026 08:40
Source
The Globe and Mail
Market source Direct company coverage

Health Catalyst and Paycom Shares Are Falling, What You Need To Know

Shares of Health Catalyst (HCAT) and Paycom (PAYC) fell significantly due to investor rotation out of high-multiple growth stocks, driven by rising inflation expectations and geopolitical tensions. The market is increasingly sensitive to AI development, with new efficient AI agen

Tone
Negative 31/100
Event
Macro sensitivity
Published
16 Jun 2026 21:53
Source
Market source
Stock Titan Direct company coverage

AI ROI: real vs hype in healthcare, Health Catalyst CEO on June 24 panel

Health Catalyst (HCAT) announced that its CEO, Ben Albert, will participate in the Truist Securities Healthcare Disruptors & Digital Health Conference on June 24, 2026. Albert will join a panel discussion titled “AI ROI in Healthcare: Real vs Hype Debate” at 3:30 PM ET. The compa

Tone
Neutral 50/100
Event
Market update
Published
16 Jun 2026 20:09
Source
Stock Titan
Healthcare IT Today Direct company coverage

Health Catalyst to Divest Vitalware for $147 Million, Accelerating Strategic Transformation

Health Catalyst announced its definitive agreement to divest Vitalware, its mid-revenue cycle business, to Med-Metrix for $147 million in cash. This strategic move aims to sharpen Health Catalyst's focus on its core technology and AI investments for driving measurable improvement

Tone
Neutral 50/100
Event
Balance sheet
Published
16 Jun 2026 12:40
Source
Healthcare IT Today
Stock Titan Direct company coverage

Health Catalyst (HCAT) CEO uses 34,485 shares to cover RSU tax bill

Health Catalyst (HCAT) CEO Albert Benjamin disposed of 34,485 shares of common stock at an average price of $1.6918 per share. This "sell to cover" transaction was mandated to satisfy tax withholding obligations related to the vesting of his restricted stock units and was not a d

Tone
Neutral 50/100
Event
Market update
Published
15 Jun 2026 20:39
Source
Stock Titan
Stock Titan Direct company coverage

Health Catalyst (HCAT) Form 144: 34,485 restricted shares planned sale 06/10/2026

Health Catalyst, Inc. (HCAT) has filed a Form 144 indicating a proposed sale of 34,485 restricted shares of Common Stock, sourced from compensation, with an intended sale date of June 10, 2026. The filing also notes prior restricted stock sales by the same holder on March 10, May

Tone
Neutral 50/100
Event
Market update
Published
11 Jun 2026 04:39
Source
Stock Titan